# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0000950170-25-064983
Filing Date
2025-05-07
Accepted
2025-05-07 07:05:19
Documents
43
Period of Report
2025-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | eypt-20250507.htm iXBRL | 8-K | 46820
2 | EX-99.1 | eypt-ex99_1.htm | EX-99.1 | 217085
3 | EX-99.2 | eypt-ex99_2.htm | EX-99.2 | 31618
4 | GRAPHIC | img96707757_0.jpg | GRAPHIC | 7650
5 | GRAPHIC | eypt-ex99_2s1.jpg | GRAPHIC | 180068
6 | GRAPHIC | eypt-ex99_2s2.jpg | GRAPHIC | 934842
7 | GRAPHIC | eypt-ex99_2s3.jpg | GRAPHIC | 432910
8 | GRAPHIC | eypt-ex99_2s4.jpg | GRAPHIC | 353062
9 | GRAPHIC | eypt-ex99_2s5.jpg | GRAPHIC | 418118
10 | GRAPHIC | eypt-ex99_2s6.jpg | GRAPHIC | 399755
11 | GRAPHIC | eypt-ex99_2s7.jpg | GRAPHIC | 307401
12 | GRAPHIC | eypt-ex99_2s8.jpg | GRAPHIC | 461253
13 | GRAPHIC | eypt-ex99_2s9.jpg | GRAPHIC | 434512
14 | GRAPHIC | eypt-ex99_2s10.jpg | GRAPHIC | 195954
15 | GRAPHIC | eypt-ex99_2s11.jpg | GRAPHIC | 397799
16 | GRAPHIC | eypt-ex99_2s12.jpg | GRAPHIC | 401685
17 | GRAPHIC | eypt-ex99_2s13.jpg | GRAPHIC | 371575
18 | GRAPHIC | eypt-ex99_2s14.jpg | GRAPHIC | 389485
19 | GRAPHIC | eypt-ex99_2s15.jpg | GRAPHIC | 178610
20 | GRAPHIC | eypt-ex99_2s16.jpg | GRAPHIC | 409027
21 | GRAPHIC | eypt-ex99_2s17.jpg | GRAPHIC | 432064
22 | GRAPHIC | eypt-ex99_2s18.jpg | GRAPHIC | 395483
23 | GRAPHIC | eypt-ex99_2s19.jpg | GRAPHIC | 323364
24 | GRAPHIC | eypt-ex99_2s20.jpg | GRAPHIC | 322301
25 | GRAPHIC | eypt-ex99_2s21.jpg | GRAPHIC | 343833
26 | GRAPHIC | eypt-ex99_2s22.jpg | GRAPHIC | 195547
27 | GRAPHIC | eypt-ex99_2s23.jpg | GRAPHIC | 429879
28 | GRAPHIC | eypt-ex99_2s24.jpg | GRAPHIC | 551397
29 | GRAPHIC | eypt-ex99_2s25.jpg | GRAPHIC | 467558
30 | GRAPHIC | eypt-ex99_2s26.jpg | GRAPHIC | 339242
31 | GRAPHIC | eypt-ex99_2s27.jpg | GRAPHIC | 422563
32 | GRAPHIC | eypt-ex99_2s28.jpg | GRAPHIC | 354669
33 | GRAPHIC | eypt-ex99_2s29.jpg | GRAPHIC | 176641
| Complete submission text file | 0000950170-25-064983.txt |  | 15619404

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
34 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | eypt-20250507.xsd | EX-101.SCH | 23898
45 | EXTRACTED XBRL INSTANCE DOCUMENT | eypt-20250507_htm.xml | XML | 4523

Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

EIN.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51122 | Film No.: 25919236
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)